Nektar Therapeutics (NKTR) Insider Trading
- $1,135,850.00
- $232,543,735.70
- Nov. 19, 2024
- Howard W Robin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 16, 2019 | SVP | 1,809 | $18.15 | Sell | $32,833.35 | |
Aug. 14, 2019 | CFO | 25,000 | $17.79 | Sell | $444,750.00 | |
July 24, 2019 | CEO | 33,334 | $32.11 | Sell | $1,070,354.74 | |
July 10, 2019 | CFO | 25,000 | $34.57 | Sell | $864,250.00 | |
July 8, 2019 | Director | 10,000 | $34.63 | Sell | $346,300.00 | |
June 17, 2019 | CFO | 25,000 | $33.71 | Sell | $842,750.00 | |
May 23, 2019 | CEO | 100,000 | $33.00 | Sell | $3,300,000.00 | |
May 21, 2019 | CEO | 33,333 | $32.93 | Sell | $1,097,655.69 | |
May 16, 2019 | SVP | 3,461 | $31.37 | Sell | $108,571.57 | |
May 16, 2019 | CFO | 3,767 | $31.37 | Sell | $118,170.79 | |
May 16, 2019 | CEO | 13,383 | $31.37 | Sell | $419,824.71 | |
May 16, 2019 | CAO | 1,928 | $31.37 | Sell | $60,481.36 | |
May 16, 2019 | COO | 4,077 | $31.37 | Sell | $127,895.49 | |
Feb. 21, 2019 | CEO | 108,882 | $42.19 | Sell | $4,593,731.58 | |
Feb. 19, 2019 | COO | 3,822 | $42.39 | Sell | $162,014.58 | |
Feb. 19, 2019 | CFO | 3,592 | $42.39 | Sell | $152,264.88 | |
Feb. 19, 2019 | CEO | 42,215 | $42.33 | Sell | $1,786,960.95 | |
Feb. 19, 2019 | CAO | 1,808 | $42.39 | Sell | $76,641.12 | |
Feb. 19, 2019 | SVP | 2,386 | $42.39 | Sell | $101,142.54 | |
Feb. 4, 2019 | SVP | 16,119 | $42.16 | Sell | $679,577.04 | |
Jan. 28, 2019 | COO | 63,000 | $42.82 | Sell | $2,697,660.00 | |
Nov. 16, 2018 | COO | 5,982 | $38.25 | Sell | $228,811.50 | |
Nov. 16, 2018 | CFO | 6,515 | $38.25 | Sell | $249,198.75 | |
Nov. 16, 2018 | CEO | 15,326 | $38.25 | Sell | $586,219.50 | |
Nov. 16, 2018 | CAO | 4,016 | $38.25 | Sell | $153,612.00 | |
Nov. 16, 2018 | SVP | 4,524 | $38.25 | Sell | $173,043.00 | |
Sept. 20, 2018 | Director | 6,750 | $56.76 | Sell | $383,130.00 | |
Sept. 4, 2018 | Director | 10,000 | $67.39 | Sell | $673,900.00 | |
Aug. 21, 2018 | Director | 30,000 | $59.96 | Sell | $1,798,800.00 | |
Aug. 17, 2018 | Director | 15,000 | $59.62 | Sell | $894,300.00 | |
Aug. 14, 2018 | Director | 34,250 | $60.60 | Sell | $2,075,550.00 | |
June 27, 2018 | CEO | 130,000 | $49.52 | Sell | $6,437,600.00 | |
June 25, 2018 | CEO | 43,334 | $51.82 | Sell | $2,245,567.88 | |
June 6, 2018 | Director | 10,000 | $60.28 | Sell | $602,800.00 | |
June 4, 2018 | Director | 1,400 | $61.99 | Sell | $86,786.00 | |
May 16, 2018 | CFO | 4,941 | $83.39 | Sell | $412,029.99 | |
May 16, 2018 | SVP | 3,435 | $83.39 | Sell | $286,444.65 | |
May 16, 2018 | COO | 4,917 | $83.39 | Sell | $410,028.63 | |
May 16, 2018 | CAO | 3,576 | $83.39 | Sell | $298,202.64 | |
May 16, 2018 | CEO | 12,791 | $83.39 | Sell | $1,066,641.49 | |
May 3, 2018 | CEO | 130,000 | $84.05 | Sell | $10,926,500.00 | |
May 3, 2018 | CFO | 90,000 | $84.05 | Sell | $7,564,500.00 | |
May 3, 2018 | Director | 25,000 | $82.80 | Sell | $2,070,000.00 | |
May 1, 2018 | CFO | 30,000 | $83.65 | Sell | $2,509,500.00 | |
May 1, 2018 | CEO | 43,334 | $83.65 | Sell | $3,624,889.10 | |
April 16, 2018 | SVP | 13,881 | $101.46 | Sell | $1,408,366.26 | |
April 9, 2018 | SVP | 160,000 | $93.06 | Sell | $14,889,600.00 | |
April 6, 2018 | Director | 25,000 | $92.14 | Sell | $2,303,500.00 | |
April 5, 2018 | SVP | 20,000 | $101.75 | Sell | $2,035,000.00 | |
March 7, 2018 | COO | 220,144 | $99.27 | Sell | $21,853,694.88 |
Insiders are both buying and selling Nektar Therapeutics stock.
The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Robert Chess, Jonathan Zalevsky, John Nicholson, Gil M Labrucherie, Howard W. Robin, Stephen K Doberstein, Jillian B Thomsen, Lutz Lingnau, Mark Andrew Wilson, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein
The most active insider trader at Nektar Therapeutics is Howard W Robin with 49 trades.
Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,286,240.28.
Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.
The most recent insider trade for Nektar Therapeutics was on Nov. 19, 2024.
The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.
The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.